MedImmune to Buy Amgen Colorado Facility?

Quote
























This is not a good place to work. The Senior Leadership team has no clue. The project is a disaster and absolutely the most poorly managed project I have ever been a part of.
 






anonymous said:
This is not a good place to work. The Senior Leadership team has no clue. The project is a disaster and absolutely the most poorly managed project I have ever been a part of.
Click to expand...

I've heard a number of people say that the work hours and expectations are ridiculous. Wasn't the plant supposed to operational by now?
 






anonymous said:
I've heard a number of people say that the work hours and expectations are ridiculous. Wasn't the plant supposed to operational by now?
Click to expand...

It is stunningly behind schedule. There are hints of a start date but nothing firm. I'm not sure whether it is a failure of the PMO, construction, automation, or a combination of these. It is concerning that there doesn't appear to be a formal schedule and there is little communication about what is really going on.
 






anonymous said:
It is stunningly behind schedule. There are hints of a start date but nothing firm. I'm not sure whether it is a failure of the PMO, construction, automation, or a combination of these. It is concerning that there doesn't appear to be a formal schedule and there is little communication about what is really going on.
Click to expand...

Sounds like a cluster. What about MFG and QC? If you aren't manufacturing what are these teams doing? Presumably supporitng validation activities?
 












anonymous said:
Any company crazy enough to hire dozens of KBI Biopharma employees is bound to fail.
Click to expand...

Get your resumes up to date!

"It's never a good day when drugs don't appear to work, and that was the case Thursday for an experimental combination of AstraZeneca medicines designed to treat lung cancer.

AstraZeneca shares fell 15 percent after the British drugmaker said its highly anticipated clinical trial, called MYSTIC, failed to show its two-drug combination extended progression-free survival, a measure of how long patients live without their cancer growing, compared with standard-of-care chemotherapy.

In London trading, it was the stock's biggest drop ever."
 


















anonymous said:
What about all of the ex-Amgen people that were hired to save the day? Dyer, Lee, Doud, Cole, Shoffner, Weber and countless others? How's that working for AZ?
Click to expand...

So far they aren't saving crap. Neither is the Facilities/Engineering Director who isn't ex-Amgen.
The entire leadership team is worthless. They should have been kicked to the curb with Darren.
 






anonymous said:
So far they aren't saving crap. Neither is the Facilities/Engineering Director who isn't ex-Amgen.
The entire leadership team is worthless. They should have been kicked to the curb with Darren.
Click to expand...

Totally agree....Shoffner has more or less been demoted back to working in Validation. And from the rest of the SLT, I don't see any efforts to get this ship back on course. I don't know if it is because it's too big of a problem for them collectively to fix, or if their skills were actually really reflected glory from Amgen. The site still won't name an actual schedule and only looks out a couple of weeks at a time...
 






anonymous said:
Totally agree....Shoffner has more or less been demoted back to working in Validation. And from the rest of the SLT, I don't see any efforts to get this ship back on course. I don't know if it is because it's too big of a problem for them collectively to fix, or if their skills were actually really reflected glory from Amgen. The site still won't name an actual schedule and only looks out a couple of weeks at a time...
Click to expand...

The 2 week look ahead means absolutely nothing. Automation consistently misses dates and nothing happens. Be prepared to run at least 10 engineering lots to shake out all the bugs.
 






All those exAmgens employees went to KBI Boulder and did nothing but make a mess and now they are messing up Medimmune. Stay away from the Amgen people. Anyway, I heard KBI got one of Coherus's drugs denied approval by the FDA because of KBI's GMP Violations! Looks like Boulder biopharmas are a mess!
 






anonymous said:
All those exAmgens employees went to KBI Boulder and did nothing but make a mess and now they are messing up Medimmune. Stay away from the Amgen people. Anyway, I heard KBI got one of Coherus's drugs denied approval by the FDA because of KBI's GMP Violations! Looks like Boulder biopharmas are a mess!
Click to expand...

KBI is a joke. They cannot do anything right.
 












anonymous said:
Why is the facility so behind schedule? Who's to blame?
Click to expand...


Management gets most of the blame. They are trying to get as many contracts from other companies as possible but cannot keep up with the schedule. They do not manage the schedule reasonably, they do not train employees, and they forced at least one employee out when he attempted to get them to follow any GMP, GDP, and safety. Also, the employees at all levels are to blame...they do not demand training, they do not demand professionalism, the do not demand a good workplace or look out for the products or their fellow employees. KBI is primarily recent graduated 20-year olds who only care a big paycheck.
 












Top Bottom
Back
Quote